Rezolute, Inc. (RZLT)
NASDAQ: RZLT · Real-Time Price · USD
2.595
-0.425 (-14.07%)
At close: Mar 13, 2026, 4:00 PM EDT
2.658
+0.063 (2.44%)
After-hours: Mar 13, 2026, 7:59 PM EDT
Rezolute Market Cap
Rezolute has a market cap or net worth of $248.34 million as of March 13, 2026. Its market cap has decreased by -8.02% in one year.
Market Cap
248.34M
Enterprise Value
129.12M
1-Year Change
-8.02%
Ranking
Category
Stock Price
$2.60
Market Cap Chart
Since November 10, 2020, Rezolute's market cap has increased from $167.00M to $248.34M, an increase of 48.70%. That is a compound annual growth rate of 7.72%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 12, 2026 | 289.00M | 32.08% |
| Dec 31, 2025 | 218.80M | -22.93% |
| Dec 31, 2024 | 283.90M | 622.39% |
| Dec 29, 2023 | 39.30M | -48.43% |
| Dec 30, 2022 | 76.20M | 3.25% |
| Dec 31, 2021 | 73.80M | -26.27% |
| Dec 31, 2020 | 100.10M | -40.06% |
| Nov 10, 2020 | 167.00M | - |
View and export this data all the way back to 2020. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Aura Biosciences | 358.16M |
| Neurogene | 357.35M |
| Climb Bio | 350.14M |
| Minerva Neurosciences | 343.60M |
| Opus Genetics | 334.48M |
| Adlai Nortye | 328.41M |
| XOMA Royalty | 324.32M |
| Foghorn Therapeutics | 321.61M |